autolus-logo.png

Autolus Ltd

R&D/Manufacturing

Membership category
Corporate Pharma

Autolus Ltd, Forest House, London, W12 7RP,

Autolus Ltd at a glance

Autolus Therapeutics plc (Nasdaq: AUTL) is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer.

About Autolus Ltd

Autolus Therapeutics plc (Nasdaq: AUTL) is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defence mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of haematological malignancies and solid tumours.

Therapeutic area(s)

Articles Autolus Ltd has contributed to